DNTH

Dianthus Therapeutics (DNTH)

About Dianthus Therapeutics (DNTH)

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.

Details

Daily high

$42.26

Daily low

$40.16

Price at open

52 Week High

$45.46

52 Week Low

$13.36

Market cap

1.8B

Dividend yield

0.00%

Volume

251

Avg. volume

675,594

P/E ratio

-11.86

Dianthus Therapeutics News